Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-23-059998

Chief Financial Officer sold 294 shares at $11.51 ($3,384)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Catinazzo Thomas Chief Financial Officer 2023-12-27 Sale −294 $11.51 $3,384 143,851 D
Open-market sales · 294 sh · avg $11.51 · $3,384
Loading xslF345X05/doc4.xml…